Opko Health (OPK) EBIT Margin (2010 - 2026)
Opko Health's (OPK) quarterly EBIT Margin came in at 4.26% in Q2 2026, up 3399.0% YoY from 0.12% in Q2 2025, and up 89.62% on a QoQ basis from 41.08% in Q1 2026.
Opko Health (OPK) EBIT Margin (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of EBIT Margin data on file, last reported at 4.26% in Q2 2026.
- Quarterly EBIT Margin rose 3399.0% year-over-year to 4.26% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 8.21% (up 2897.0% YoY) and the FY2025 annual result came in at 19.35%, up 198.0% from the prior year.
- EBIT Margin improved to 4.26% in Q2 2026, from 41.08% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 31.68% in Q3 2025 to a low of 1223.76% in Q1 2023.
- A 5-year average of 95.46% and a median of 36.06% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2023 — EBIT Margin sank 120176 bps — and 2024, when it jumped 118261 bps.
- Tracing OPK's EBIT Margin over 5 years: stood at 29.82% in 2022, then decreased by 27 bps to 37.96% in 2023, then surged by 41 bps to 22.46% in 2024, then decreased by 15 bps to 25.81% in 2025, then soared by 83 bps to 4.26% in 2026.
- The last three EBIT Margin figures came in at 4.26% (Q2 2026), 41.08% (Q1 2026), and 25.81% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Opko Health | 1.02 Bn | 718.85 Mn | 80.02 Mn | -4.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.26% |
| Mar 31, 2026 | -41.08% |
| Dec 31, 2025 | -25.81% |
| Sep 30, 2025 | 31.68% |
| Jun 30, 2025 | -38.25% |
| Mar 31, 2025 | -44.79% |
| Sep 30, 2024 | -22.46% |
| Jun 30, 2024 | -37.41% |
| Mar 31, 2024 | -41.15% |
| Dec 31, 2023 | -37.96% |
| Sep 30, 2023 | -36.06% |
| Jun 30, 2023 | 2.65% |
| Mar 31, 2023 | -1,223.76% |
| Dec 31, 2022 | -29.82% |
| Sep 30, 2022 | -48.86% |
| Jun 30, 2022 | -3.47% |
| Mar 31, 2022 | -22.00% |
| Dec 31, 2021 | -15.72% |
| Sep 30, 2021 | 9.80% |
| Jun 30, 2021 | 1.26% |